Seza Özen

30.6k total citations · 1 hit paper
335 papers, 9.5k citations indexed

About

Seza Özen is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Seza Özen has authored 335 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Molecular Biology, 116 papers in Immunology and 98 papers in Hematology. Recurrent topics in Seza Özen's work include Inflammasome and immune disorders (179 papers), Autoimmune and Inflammatory Disorders Research (90 papers) and Vasculitis and related conditions (58 papers). Seza Özen is often cited by papers focused on Inflammasome and immune disorders (179 papers), Autoimmune and Inflammatory Disorders Research (90 papers) and Vasculitis and related conditions (58 papers). Seza Özen collaborates with scholars based in Türkiye, United States and Italy. Seza Özen's co-authors include Yelda Bilginer, Ayşı̇n Bakkaloğlu, Ezgi Deniz Batu, Nesrin Beşbaş, Selcan Demir, U Saatçi, Erdal Sağ, Rezan Topaloğlu, Isabelle Koné‐Paut and Ahmet Nayır and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Seza Özen

312 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

2009 885 citations Murim Choi, Ute I. Scholl et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Seza Özen

Since Specialization

Citations

This map shows the geographic impact of Seza Özen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seza Özen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seza Özen more than expected).

Fields of papers citing papers by Seza Özen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seza Özen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seza Özen. The network helps show where Seza Özen may publish in the future.

Co-authorship network of co-authors of Seza Özen

This figure shows the co-authorship network connecting the top 25 collaborators of Seza Özen. A scholar is included among the top collaborators of Seza Özen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seza Özen. Seza Özen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pediatric rheumatology on social media: experts ensure accuracy, public drives engagement – a comparative analysis 2025 ·Rheumatology International ·Saverio La Bella, Marina Attanasi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Chiarelli, Seza Özen, Marco Gattorno, Luciana Breda	1
2	5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation 2024 ·Frontiers in Immunology ·Burcu Temizoz, (unknown), (unknown), Tomoya Hayashi, Kouji Kobiyama, Michelle Sue Jann Lee, (unknown), Erdal Sağ, Atsushi Kumanogoh, Masahiro Yamamoto, Mayda Gürsel, Seza Özen, Etsushi Kuroda, Cevayir Coban, Ken J. Ishii	14
3	Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey 2024 ·Journal of Clinical Medicine ·Jürgen Rech, Georg Schett, Abdurrahman Tufan, Jasmin Kuemmerle‐Deschner, Seza Özen, Koray Taşçılar, (unknown), (unknown), (unknown), Tatjana Welzel, (unknown), (unknown)	1
4	Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center 2024 ·European Radiology ·Üstün Aydıngöz, Adalet Elçin Yıldız, (unknown), Ezgi Deniz Batu, Seza Özen	6
5	POS0740 VALIDATION OF THE PEDIATRIC BEHÇET DISEASE CRITERIA (PEDBD): A REAL LIFE CONSENSUS-BASED APPROACH 2023 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Sulaiman M. Al‐Mayouf, Paul Brogan, Luca Cantarini, Ahmet Gül, Özgür Kasapçopur, J. B. Kuemmerle‐Deschner, Seza Özen, David Saadoun, Farhad Shahram, (unknown), Nicolino Ruperto, Marco Gattorno, Isabelle Kone‐Paut	0
6	Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients 2023 ·Journal of Molecular Medicine ·(unknown), Yeliz Z. Akkaya‐Ulum, Ezgi Deniz Batu, Federica Penco, Helmut Wittkowski, (unknown), Mariëlle van Gijn, Dirk Foell, Marco Gattorno, Seza Özen, Banu Balcı‐Peynircioğlu	7
7	Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever 2023 ·Modern Rheumatology ·Seher Şener, Erdal Atalay, Adalet Elçin Yıldız, Müşerref Kasap Cüceoğlu, Özge Başaran, Ezgi Deniz Batu, Yelda Bilginer, Seza Özen	3
8	Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach 2023 ·Lara D. Veeken ·(unknown), (unknown), Sulaiman M. Al‐Mayouf, Paul Brogan, Luca Cantarini, Ahmet Gül, Özgür Kasapçopur, Jasmin Kuemmerle‐Deschner, Seza Özen, David Saadoun, Farhad Shahram, Francesca Bovis, (unknown), Nicolino Ruperto, Marco Gattorno, Isabelle Kone‐Paut	3
9	Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed? 2022 ·Journal of Clinical Medicine ·Müşerref Kasap Cüceoğlu, Özge Başaran, Özge Soyer, Seza Özen	0
10	Biological classification of childhood arthritis: roadmap to a molecular nomenclature 2021 ·Nature Reviews Rheumatology ·Peter A. Nigrović, Robert A. Colbert, V. Michael Holers, Seza Özen, Nicolino Ruperto, Susan D. Thompson, Lucy R. Wedderburn, Rae S. M. Yeung, Alberto Martini	59
11	Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature 2021 ·Nature Reviews Rheumatology ·Peter A. Nigrović, Robert A. Colbert, V. Michael Holers, Seza Özen, Nicolino Ruperto, Susan D. Thompson, Lucy R. Wedderburn, Rae S. M. Yeung, Alberto Martini	2
12	Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura 2021 ·Journal of Pediatric Urology ·Ümmüşen Kaya Akça, Ezgi Deniz Batu, (unknown), (unknown), (unknown), Özlem Tekşam, Yelda Bilginer, Seza Özen	3
13	Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial 2020 ·Annals of the Rheumatic Diseases ·Seza Özen, (unknown), Ivan Foeldvari, Gil Amarilyo, Huri Özdoğan, Steven Vanderschueren, (unknown), J. Michelle Kahlenberg, Elise Dekker, Fabrizio De Benedetti, Isabelle Koné‐Paut	50
14	The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus 2020 ·The Journal of Rheumatology ·Ezgi Deniz Batu, Ümmüşen Kaya Akça, Ayşenur Paç Kısaarslan, Erdal Sağ, Ferhat Demir, Selcan Demir, (unknown), (unknown), Betül Sözeri, Yelda Bilginer, Seza Özen	30
15	Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases 2019 ·Pediatric Allergy and Immunology ·Özge Soyer, Selcan Demir, Yelda Bilginer, Ezgi Deniz Batu, Hafize Emine Sönmez, Zehra Serap Arıcı, Ümit Murat Şahiner, Bülent Enis Şekerel, Seza Özen	21
16	Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. 2018 ·PubMed ·Hafize Emine Sönmez, Ezgi Deniz Batu, Selcan Demir, Yelda Bilginer, Seza Özen	18
17	FRI0271 Final Evidence-Based Recommendations for Diagnosis and Treatment of Paediatric Vasculitides 2015 ·Annals of the Rheumatic Diseases ·Nienke de Graeff, Noortje Groot, Sylvia Kamphuis, Tadej Avčin, Brigitte Bader‐Meunier, Pavla Doležalová, Isabelle Koné‐Paut, Pekka Lahdenne, Liza McCann, (unknown), Angelo Ravelli, Annet van Royen, Sebastiaan J. Vastert, Nico Wulffraat, Seza Özen, Paul Brogan, MW Beresford	2
18	Are MEFV mutations susceptibility factors in enthesitis-related arthritis patients in the eastern Mediterranean? 2014 ·PubMed ·Bora Gülhan, (unknown), Levent Özçakar, Nesrin Beşbaş, Seza Özen	13
19	Genetic diagnosis by whole exome capture and massively parallel DNA sequencing breakdown → 2009 ·Proceedings of the National Academy of Sciences ·Murim Choi, Ute I. Scholl, Weizhen Ji, (unknown), Irina R. Tikhonova, Paul Zumbo, Ahmet Nayır, Ayşı̇n Bakkaloğlu, Seza Özen, Sami A. Sanjad, Carol Nelson‐Williams, Anita Farhi, Shrikant Mane, Richard P. Lifton	885
20	Takayasu arteritis in children. 2008 ·PubMed ·Nilgün Çakar, Fatoş Yalçınkaya, Ali Düzova, Salim Çalışkan, Aydan Şirin, Ayşe Öner, Esra Baskın, Kenan Bek, Alper Soylu, Suat Fítöz, Aysun Karabay Bayazıt, Zelâl Bircan, Seza Özen, Nermin Uncu, Mesiha Ekim	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact